PONTE VEDRA, Fla., Dec. 11, 2025 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition...
Art Pappas will moderate the panel "Driving Innovation from a VC Perspective" at the BioExec Institute Retreat in Florida on March 21, 2013.
News | 03. 21. 2013
Art Pappas will moderate a panel titled, "Driving Innovation from a VC Perspective" at the BioExec Institute Retreat in Florida on March 21, 2013.
